2023-08-07 07:56:44 ET
- Clinical-stage precision oncology company, Viracta Therapeutics ( NASDAQ: VIRX ) appoints Darrel P. Cohen, M.D., Ph.D. as Chief Medical Officer or CMO, effective immediately.
- Dr. Cohen has more than 25 years of global clinical research and drug development experience.
- He will oversee the clinical development and regulatory advancement of Nana-val in Epstein-Barr virus-associated malignances, contribute to the strategic expansion of Viracta’s pipeline, and serve on the executive leadership team.
For further details see:
Viracta Therapeutics gets new chief medical officer